NACDS - National Association of Chain Drug Stores

03/08/2019 | Press release | Distributed by Public on 03/08/2019 12:45

NACDS Urges DIR Fee Reform in Morning Consult Op-Ed NACDS President & CEO Steven C. Anderson emphasizes DIR fee reform’s role in lowering patients’ out of pocket costs,[...]

'The amount that Medicare beneficiaries must pay for a prescription drug is supposed to be based on the cost of the drug. However, health plans often calculate patients' drug prices without subtracting the dollars that the plans claw back from pharmacies many months after the prescription is dispensed. So, patients' drug costs are artificially inflated, because they are calculated based on an inflated base figure that is more than the plans really pay for drugs. HHS has concluded that eliminating this drug pricing game would reduce patients' drug costs by an astounding $14.8 billion over 10 years.'

'To summarize, it is simply unsustainable for pharmacies - or for any business - to be undercompensated, often below cost, for goods and services, and for this reimbursement to be completely unpredictable. That is just the beginning of the story, as the unsustainable cycle proceeds from there: higher drug costs, lower medication adherence, diminished patient health, greater reliance on expensive treatments, higher overall healthcare costs.'